| 英文别名 |
Cephapirin benzathine;CEPHAPIRIN BENZATHINE (100 MG);(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-{[(4-pyridinylsulfanyl)acetyl]a mino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid - N,N '-dibenzyl-1,2-ethanediamine (2:1);1,2-Ethanediamine, N,N′-bis(phenylmethyl)-, bis[(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate] (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R,7R)-, compd. with N,N′-bis(phenylmethyl)-1,2-ethanediamine (2:1) (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R-trans)-, compd. with N,N′-bis(phenylmethyl)-1,2-ethanediamine (2:1) (ZCI);Metricure;CEPHAPIRIN BENZATHINE [USP IMPURITY];CEPHAPIRIN BENZATHINE (USP-RS);CEPHAPIRIN BENZATHINE (USP IMPURITY);Cephapirin benzathine (USP);Cefa-Dri;CEPHAPIRIN BENZATHINE [GREEN BOOK];CEPHAPIRIN BENZATHINE (USP MONOGRAPH);UNII-90G868409O;Q27271322;DA-72088;CCG-270637;E77135;ToMORROW;CEPHAPIRIN COMPD WITH N,N'-DIBENZYLETHYLENEDIAMINE;97468-37-6;D07637;CS-0063059;(6R,7R)-3-(Hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid compound with N,N'-dibenzylethylenediamine (2:1);Cephapirin benzathine [USP];Cefapirinbenzathine;s4875;CEPHAPIRIN COMPD WITH N,N'-DIBENZYLETHYLENEDIAMINE [MI];Cefa-Dri (TN);ToMORROW intramammary infusion;HY-113735;90G868409O;Cefapirin (sodium);SCHEMBL467178;Cefapirin benzathine;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;N,N'-dibenzylethane-1,2-diamine;CEPHAPIRIN BENZATHINE [USP-RS];AKOS032944865;CHEMBL3989837;CEPHAPIRIN BENZATHINE [USP MONOGRAPH] |
微信公众号
客服
